
Exploring critical infrastructure and legislative barriers limiting energy innovation, panelists at an energy strategy briefing discussed collaborative solutions and regulatory reform as essential to positioning Utah as a global leader in AI, data centers, and clean power deployment.
by Mark Tullis
Nusano (West Valley City, UT) will supply isotopes iodine-125 and actinium-225 to Cellectar Biosciences (Florham Park, NJ) under a new agreement, supporting development of radiotherapeutics including CLR 125 for breast cancer and CLR 225 for pancreatic cancer.
by Mark Tullis
Amplēo (Lehi, UT) has secured a strategic investment from Unity Partners LP (Dallas, TX) to accelerate growth, expand services, and boost national reach in fractional finance, marketing, HR, and valuation—cementing its leadership in managed professional services.
by Mark Tullis
Sorenson Capital (Lehi, UT and Palo Alto, CA) has launched its $150M Ventures III fund, reaffirming its focused investment strategy in early-stage cybersecurity and B2B software startups, emphasizing hands-on support, consistent fund sizing, and long-term sector expertise.
by Mark Tullis
The University of Utah's Eccles School announced it has been ranked within the top 5 in public schools for MBA and undergrad entrepreneurship.
by Mark Tullis
Silicon Slopes announces a relaunch of Summit, in partnership with Visit Salt Lake. It aims to be a be a citywide festival, blending tech, culture, and entrepreneurship through keynotes, workshops, and performances to spotlight Utah’s economic and creative leadership.
by Mark Tullis
Alysio (Salt Lake City, UT) launches a major platform update, introducing real-time revenue insights and a new category, “Revenue Security,” to unify GTM data and empower revenue teams with AI-driven clarity and faster decision-making.
by Mark Tullis
A recently announced partnership between Nusano (West Valley City, UT) and dGenThera (Durham, NC) secures At-211 supply, advancing targeted alpha therapies for precision cancer treatment, leveraging innovative theranostics and scalable isotope production.
by Mark Tullis